Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) after Subcutaneous (s. c.) Administration (adm) of BIM23A760, a Chimeric Compound Combining Dopaminergic Agonist and Somatostatin Analogue, in Healthy Male Volunteers - Froehlich, J; Ramis, J; Lesage, C; Obach, R (91st Annual Meeting of the Endocrine Society, Washington, DC, 2009)
Abstract P3-685